AU616502B2 - Treatment of inflammatory disorders in humans - Google Patents

Treatment of inflammatory disorders in humans Download PDF

Info

Publication number
AU616502B2
AU616502B2 AU33006/89A AU3300689A AU616502B2 AU 616502 B2 AU616502 B2 AU 616502B2 AU 33006/89 A AU33006/89 A AU 33006/89A AU 3300689 A AU3300689 A AU 3300689A AU 616502 B2 AU616502 B2 AU 616502B2
Authority
AU
Australia
Prior art keywords
acid
polyunsaturated fatty
effective amount
fatty acids
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU33006/89A
Other languages
English (en)
Other versions
AU3300689A (en
Inventor
Michael Wellesley Dr. Whitehouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Publication of AU3300689A publication Critical patent/AU3300689A/en
Application granted granted Critical
Publication of AU616502B2 publication Critical patent/AU616502B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU33006/89A 1988-04-22 1989-04-14 Treatment of inflammatory disorders in humans Ceased AU616502B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI786888 1988-04-22
AUPI7868 1988-04-22

Publications (2)

Publication Number Publication Date
AU3300689A AU3300689A (en) 1989-10-26
AU616502B2 true AU616502B2 (en) 1991-10-31

Family

ID=3773040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33006/89A Ceased AU616502B2 (en) 1988-04-22 1989-04-14 Treatment of inflammatory disorders in humans

Country Status (5)

Country Link
AU (1) AU616502B2 (fr)
DE (1) DE3913194A1 (fr)
FR (1) FR2630648A1 (fr)
GB (1) GB2217602A (fr)
NZ (1) NZ228862A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108623448A (zh) * 2018-05-15 2018-10-09 南京医科大学 亚麻酸锌的制备及其在制备抗幽门螺杆菌药物中的应用

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69124415T2 (de) * 1990-04-27 1997-05-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
US5302617A (en) * 1990-04-27 1994-04-12 Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
CA2046069C (fr) * 1990-07-10 2002-04-09 Ryuji Ueno Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
GB9323808D0 (en) * 1993-11-18 1994-01-05 Alpha Healthcare Ltd Composition containing zinc for the treatment of skin disorders
DE4439930C2 (de) * 1994-11-08 1996-10-10 Hudelmaier Ulrike Vorrichtung zum Pumpen von Beton
KR19980701452A (ko) * 1995-01-18 1998-05-15 우에하라 아끼라 피부염 치료제(Remedy for Dermatitis)
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
CA2303833A1 (fr) * 1997-07-18 1999-01-28 Patrick D. Kelly Lubrifiants genitaux contenant du zinc destine a reduire les irritations et les reactions allergiques
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
GB9918023D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
AU2003224767A1 (en) 2002-03-26 2003-10-13 Eastern Virginia Medical School Suramin and derivatives thereof as topical microbicide and contraceptive
FR2873295B1 (fr) * 2004-07-26 2006-12-01 Expanscience Sa Lab Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
WO2007066232A2 (fr) * 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Sels d'acides gras et procedes de fabrication et d'utilisation de ces derniers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309415A (en) * 1978-04-11 1982-01-05 Verronmay Limited Method and composition for treating inflammatory disorders
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB798655A (en) * 1956-03-15 1958-07-23 Biorex Laboratories Ltd Improvements in or relating to therapeutic compositions
GB943282A (en) * 1960-10-13 1963-12-04 Peter James Shannon Hair restorer
FR2406775A1 (fr) * 1977-10-19 1979-05-18 Fmc Europe Dispositif de couplage a deconnexion rapide pour applications cryogeniques
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
JPS5529524A (en) * 1978-08-21 1980-03-01 Toyo Aerosol Kogyo Kk Powdery aerosol composition
DE3152555T1 (de) * 1980-11-24 1982-12-02 Alan J Brock Pharmaceutical compound and method
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
WO1986000251A1 (fr) * 1984-06-22 1986-01-16 The Taylor-Winfield Corporation Machine a souder robot
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
GB2191941B (en) * 1985-08-27 1990-03-14 Glyzinc Pharma Ltd Zinc glycerolate complex and additions for pharmaceutical applications

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4309415A (en) * 1978-04-11 1982-01-05 Verronmay Limited Method and composition for treating inflammatory disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108623448A (zh) * 2018-05-15 2018-10-09 南京医科大学 亚麻酸锌的制备及其在制备抗幽门螺杆菌药物中的应用

Also Published As

Publication number Publication date
NZ228862A (en) 1991-03-26
DE3913194A1 (de) 1989-11-02
GB8908831D0 (en) 1989-06-07
GB2217602A (en) 1989-11-01
AU3300689A (en) 1989-10-26
FR2630648A1 (fr) 1989-11-03

Similar Documents

Publication Publication Date Title
AU616502B2 (en) Treatment of inflammatory disorders in humans
US5118671A (en) Complexes of aescin, β-sitosterol or cholesterol, and phospholipids and pharmaceutical compositions containing them
EP0481007B1 (fr) VEHICULES A LIBERATION LENTE REDUISANT AU MINIMUM L'IRRITATION DERMIQUE DUE A DES COMPOSITIONS A USAGE LOCAL contenant des rétinoides
JPH10245337A (ja) 薬学的組成物
HU206973B (en) Process for producing pharmaceutical compositions comprising flupirin as active ingredient
AU740443B2 (en) Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
JPH07300421A (ja) 抗炎症剤
US4621075A (en) Gel-form topical antibiotic compositions
CN114126581A (zh) 包含十六烷化脂肪酸的组合物及其用于治疗关节炎和关节炎症的用途
DE3938227C1 (en) Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
US5444076A (en) Pharmaceutical preparation for topical application
JPH05331050A (ja) 消炎鎮痛外用剤
EP0429856B1 (fr) Préparations pharmaceutiques contenant un sel métallique de l'ibuprofène et son procédé de fabrication
JP3215133B2 (ja) 消炎鎮痛外用剤
JP3231079B2 (ja) 消炎鎮痛外用剤
EP0492747A2 (fr) Préparation pharmaceutique pour application topique
JP3208719B2 (ja) 消炎鎮痛外用剤
JPH06316553A (ja) アルカノールアミンの用途
FR2649322A1 (fr) Complexes biodisponibles d'acide (alpha)-linolenique, extraits de plantes en contenant et compositions pharmaceutiques les incorporant
BE1000535A4 (fr) Composition pharmaceutique injectable a base d'amoxicilline.
PL200231B1 (pl) Środek farmaceutyczny i/lub kosmetyczny zawierający kwas pantotenowy i/lub jego pochodne oraz zastosowanie mieszaniny kwasu pantotenowego i/lub jego pochodnych
US20220220414A1 (en) Method for preparing a composition comprising cetylated fatty acids
JP2516477B2 (ja) 皮膚の血行不良に起因する疾患の治療剤
CN114126602A (zh) 用于治疗胃粘膜、糖尿病和高血糖水平的包含十六烷化脂肪酸的组合物
JP3153596B2 (ja) 消炎鎮痛外用剤